I agree that this site is using cookies. You can find further informations here.
X
Chamuleau, M.
~ 500  results:
Search for persons X
?
1

R‐CODOX‐M/R‐IVAC VERSUS DA‐EPOCH‐R IN PATIENTS WITH NEWLY D..:

Chamuleau, M. ; Stenner, F. ; Chitu, D....
Hematological Oncology.  41 (2023)  S2 - p. 50-51 , 2023
Link: https://doi.org/10.1002/..
 
?
2

PHASE 3 TRIAL OF SUBCUTANEOUS EPCORITAMAB + R‐CHOP VERSUS R..:

Sehn, L. H ; Chamuleau, M. ; Lenz, G....
Hematological Oncology.  41 (2023)  S2 - p. 849-850 , 2023
Link: https://doi.org/10.1002/..
 
?
3

Unraveling the mechanisms of c‐MYC‐mediated escape from ant..:

de Jonge, V. ; Csikós, T. ; Eken, M....
Hematological Oncology.  41 (2023)  S2 - p. 258-260 , 2023
Link: https://doi.org/10.1002/..
 
?
4

ZUMA‐23: A GLOBAL, PHASE 3, RANDOMIZED CONTROLLED STUDY OF ..:

Westin, J. ; Jacobson, C. A. ; Chavez, J. C....
Hematological Oncology.  41 (2023)  S2 - p. 171-173 , 2023
Link: https://doi.org/10.1002/..
 
?
5

MYC negatively impacts treatment outcomes in stage II, but ..:

de Jonge, V. ; Bult, J. ; Karssing, D....
Hematological Oncology.  41 (2023)  S2 - p. 298-299 , 2023
Link: https://doi.org/10.1002/..
 
?
6

P1254: RESPONSE TO DA-EPOCH-R IN PATIENTS WITH HIGH GRADE B..:

de Jonge, V. ; Duetz, C. ; Bruins, W....
HemaSphere.  6 (2022)  - p. 1139-1140 , 2022
Link: https://doi.org/10.1097/..
 
?
7

P1462: POPULATION-BASED REAL WORLD RESULTS OF CD19-DIRECTED..:

Spanjaart, A. M. ; Pennings, E. ; Mutsaers, P....
HemaSphere.  6 (2022)  - p. 1344-1345 , 2022
Link: https://doi.org/10.1097/..
 
?
8

POPULATION‐BASED STUDY ON DIFFERENT REGIMENS OF R‐CHOP IN P..:

Issa, D. ; Dinmohamed, A. ; Wondergem, M....
Hematological Oncology.  37 (2019)  S2 - p. 252-253 , 2019
Link: https://doi.org/10.1002/..
 
?
9

THE RISK OF TRANSFORMATION OF FOLLICULAR LYMPHOMA "TRANSFOR..:

Federico, M. ; Caballero, D. ; Marcheselli, L....
Hematological Oncology.  35 (2017)  S2 - p. 115-116 , 2017
Link: https://doi.org/10.1002/..
 
?
10

5.3 R-DHAP Immuno-Chemotherapy is an Effective Remission-In..:

van Gelder, M. ; Ghidey, W. ; Chamuleau, M....
Clinical Lymphoma Myeloma and Leukemia.  11 (2011)  - p. S244 , 2011
Link: https://doi.org/10.1016/..
 
?
11

P043 Aberrant immunophenotype of blasts in low and intermed..:

Westers, T. ; Alhan, C. ; Van der Vorst, M....
Leukemia Research.  33 (2009)  - p. S83 , 2009
Link: https://doi.org/10.1016/..
 
?
12

A MYC-rearrangement is a negative prognostic factor in stag..:

de Jonge, A. V. ; Bult, J. A. A. ; Karssing, D. F. E....
Blood Cancer Journal.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
13

Differences in baseline PET/CT lymphoma distribution patter..:

Croese, K. J. ; Zwezerijnen, G. J. C. ; Bes, A. L....
Hematological Oncology.  41 (2023)  S2 - p. 345-346 , 2023
Link: https://doi.org/10.1002/..
 
?
14

R‐miniCHOP versus R‐CHOP in elderly patients with diffuse l..:

Al‐Sarayfi, D. ; Brink, M. ; Chamuleau, M. E. D....
American Journal of Hematology.  99 (2023)  2 - p. 216-222 , 2023
Link: https://doi.org/10.1002/..
 
?
15

P1105: FINAL RESULTS OF THE PHASE I/II HOVON124/ECWM-R2 STU..:

Dimopoulos, M.-A. ; Amaador, K. ; Minnema, M. C....
HemaSphere.  6 (2022)  - p. 995-996 , 2022
Link: https://doi.org/10.1097/..
 
1-15